Valorisation-Recherche, Limited Partnership
10 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
4
Ending by 2030
Jun 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 16, 2027The maintenance fee for Steric-hindrance hybridization systems, assays and methods associated thereto (US 10,352,928) comes due Jan 16, 2027. Unpaid by Jul 16, 2027, it lapses early.
- 1 fee due Feb 6, 2027The maintenance fee for Method of and system for processing signals sensed from a user (US 10,368,741) comes due Feb 6, 2027. Unpaid by Aug 6, 2027, it lapses early.
- 1 fee due Jul 30, 2027The maintenance fee for Chalcogen-grafted carbon materials and processes for their preparation (US 11,884,547) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 21, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US RE45,467 | Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications In force · USPTO record | In force | USPTO record | |
| US RE46,285 | Streptococcus suis polypeptides and polybnucleotides encoding same and their use in vaccinal and diagnostic applications In force · USPTO record | In force | USPTO record | |
| US RE47,164 | Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications In force · USPTO record | In force | USPTO record | |
| US 8,982,353 | High Resolution Surface Plasmon Resonance Instrument Using a Dove Prism In force · High confidence | In force | High confidence | |
| US 10,209,194 | Raman Scattering Nanoprobes In force · Medium confidence | In force | Medium confidence | |
| US 8,993,515 | Peptidomimetics Comprising N-Amino Cyclic Urea Residues and Uses Thereof In force · High confidence | In force | High confidence | |
| US 10,092,574 | Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof In force · USPTO record | In force | USPTO record | |
| US 10,352,928 | Steric-hindrance hybridization systems, assays and methods associated thereto In force · USPTO record | In force | USPTO record | |
| US 10,290,155 | 3D Virtual Environment Interaction System In force · High confidence | In force | High confidence | |
| US 10,368,741 | Method of and system for processing signals sensed from a user In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 12: 10 patents in force now held by others · 40 lapsed for an unpaid fee · 9 ended at full term · 1 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 10 no status recorded